SPIMACO’s Moroccan plant to begin trial run in Q4 2019
25/03/2019
Argaam

Saudi Pharmaceutical Industries and Medical Appliances (SPIMACO) expects pilot operations at Morocco’s facility to commence in the fourth quarter of the year.
Electrical and mechanical construction services at the Casablanca-based pharmaceutical plant were completed, SPIMACO said in a bourse statement on Monday.
However, the qualification process was rescheduled to begin in Q3 2019, due to a delay in receiving the required equipment.
The related financial impact will be announced later on, the pharmaceutical producer added.
Market Indices
TASI
10,542.23
(47.72)
(0.45 %)
Quotes
SPIMACO
31.22
0.26
0.84%
Call Request
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}